Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing investment in this field is indicative of global market opportunities for CRISPR-Cas9 over existing alternatives. The objective of this study is to explore the market and patenting activity in CRISPR-Cas9 gene editing technology. This study considers issued patents and pending published applications related to CRISPR-Cas9 published since January 1, 2007. Search strategies using various combinations of keywords, classification codes, and prominent assignees resulted in moreContinue reading
This infographic features the top patent awardees of 2016 in different segments based on USPTO data. This segmentation can serve as a reference point for performing deeper analysis to support patent prosecution strategies, product marketing strategies, as well as global acquisition and licensing strategies.Continue reading
MaxVal has recapped all the latest US patent trends from the first half of 2016.
The total number of patents issued by the USPTO between Jan’16 to June ‘16 is 168,077.